Rhythm Pharmaceuticals, Inc. RYTM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s shares (diluted)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported shares (diluted) of 68M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s shares (diluted) increased by 7.8% year-over-year, from 63.1M to 68M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s shares (diluted) has grown at a 6.8% compound annual growth rate (CAGR), from 198.6M to 258M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.